Advanced Biomed Inc.

ADVB · NASDAQ

Advanced Biomed has historical cancer-diagnostics technology, but the latest filings show no product revenue, a reverse split, a short-term loan, a subsidiary divestiture, and an April 2026 pivot into AI.

Follow Add to Watchlist Ask Question

NASDAQ ADVB Coverage Bootstrap Diagnostics Artificial Intelligence Microcap

Latest ReportMay 14, 2026Advanced Biomed: The No-Revenue Biotech That Just Swerved Into AIView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->

Company filters1 of 1 reports match

Clear filters

Add tags

Selected tags

DiagnosticsNasdaqMicrocap

Clear tags

MatchAny tag

Latest Thesis

Advanced Biomed: The No-Revenue Biotech That Just Swerved Into AI

May 14, 2026Research reportSlides available

Read report Open slides Discussion (0)

Advanced Biomed Inc.Biomed: The No-Revenue Biotech That Just Swerved Into AIMay 14, 2026

Member workspace

Financials and workspace tools are for paid members.

Paid login unlocks company financials, filing timeline, peer comparison, scorecard, and discussion. Valuation remains admin-only while we finalize market-data licensing.

Recent Reports

Compact report index for this company.

View all 1 reports ->